Psychology and Neuroscience Faculty Database
Psychology and Neuroscience
Arts & Sciences
Duke University

 HOME > Arts & Sciences > pn > Faculty    Search Help Login pdf version printable version 

Publications of Scott H. Kollins    :chronological  combined  bibtex listing:

search PubMed.

Journal Articles

  1. Mitchell, JT; Sweitzer, MM; Tunno, AM; Kollins, SH; McClernon, FJ (2016). "I Use Weed for My ADHD": A Qualitative Analysis of Online Forum Discussions on Cannabis Use and ADHD.. Plos One, 11(5), e0156614. [doi]  [abs]
  2. Wigal, SB; Kollins, SH; Childress, AC; Squires, L; 311 Study Group, (2009). A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder.. Child and Adolescent Psychiatry and Mental Health, 3(1), 17. [19508731], [doi]  [abs]
  3. Swanson, JM; Wigal, SB; Wigal, T; Sonuga-Barke, E; Greenhill, LL; Biederman, J; Kollins, S; Nguyen, AS; DeCory, HH; Hirshe Dirksen, SJ; Hatch, SJ; COMACS Study Group, (2004). A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).. Pediatrics, 113(3 Pt 1), e206-e216. [doi]  [abs]
  4. Kratochvil, CJ; Vaughan, BS; Stoner, JA; Daughton, JM; Lubberstedt, BD; Murray, DW; Chrisman, AK; Faircloth, MA; Itchon-Ramos, NB; Kollins, SH; Maayan, LA; Greenhill, LL; Kotler, LA; Fried, J; March, JS (2011). A double-blind, placebo-controlled study of atomoxetine in young children with ADHD.. Pediatrics, 127(4), e862-e868. [21422081], [doi]  [abs]
  5. Wigal, SB; McGough, JJ; McCracken, JT; Biederman, J; Spencer, TJ; Posner, KL; Wigal, TL; Kollins, SH; Clark, TM; Mays, DA; Zhang, Y; Tulloch, SJ (2005). A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder.. Journal of Attention Disorders, 9(1), 275-289. [16371674], [doi]  [abs]
  6. Kollins, SH; DeLoss, DJ; Cañadas, E; Lutz, J; Findling, RL; Keefe, RSE; Epstein, JN; Cutler, AJ; Faraone, SV (2020). A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial.. The Lancet Digital Health, 2(4), e168-e178. [doi]  [abs]
  7. Adjei, AL; Chaudhary, I; Kollins, SH; Padilla, A (2020). A Pharmacokinetic Study of Methylphenidate Hydrochloride Multilayer Extended-Release Capsules (Aptensio XR®) in Preschool-Aged Children with Attention-Deficit/Hyperactivity Disorder.. Paediatr Drugs, 22(5), 561-570. [doi]  [abs]
  8. Kratochvil, CJ; Vaughan, BS; Mayfield-Jorgensen, ML; March, JS; Kollins, SH; Murray, DW; Ravi, H; Greenhill, LL; Kotler, LA; Paykina, N; Biggins, P; Stoner, J (2007). A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder.. Journal of Child and Adolescent Psychopharmacology, 17(2), 175-185. [17489712], [doi]  [abs]
  9. Kollins, SH; English, JS; Itchon-Ramos, N; Chrisman, AK; Dew, R; O'Brien, B; McClernon, FJ (2014). A pilot study of lis-dexamfetamine dimesylate (LDX/SPD489) to facilitate smoking cessation in nicotine-dependent adults with ADHD.. J Atten Disord, 18(2), 158-168. [22508760], [doi]  [abs]
  10. MacDonald Fredericks, E; Kollins, SH (2005). A pilot study of methylphenidate preference assessment in children diagnosed with attention-deficit/hyperactivity disorder.. Journal of Child and Adolescent Psychopharmacology, 15(5), 729-741. [16262590], [doi]  [abs]
  11. Mitchell, JT; McIntyre, EM; English, JS; Dennis, MF; Beckham, JC; Kollins, SH (2017). A Pilot Trial of Mindfulness Meditation Training for ADHD in Adulthood: Impact on Core Symptoms, Executive Functioning, and Emotion Dysregulation.. J Atten Disord, 21(13), 1105-1120. [24305060], [doi]  [abs]
  12. Bidwell, LC; Garrett, ME; McClernon, FJ; Fuemmeler, BF; Williams, RB; Ashley-Koch, AE; Kollins, SH (2012). A preliminary analysis of interactions between genotype, retrospective ADHD symptoms, and initial reactions to smoking in a sample of young adults.. Nicotine Tob Res, 14(2), 229-233. [21778150], [doi]  [abs]
  13. Kollins, SH (2008). A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.. Curr Med Res Opin, 24(5), 1345-1357. [18384709], [doi]  [abs]
  14. Wigal, SB; Greenhill, LL; Nordbrock, E; Connor, DF; Kollins, SH; Adjei, A; Childress, A; Stehli, A; Kupper, RJ (2014). A randomized placebo-controlled double-blind study evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children with attention-deficit/hyperactivity disorder.. J Child Adolesc Psychopharmacol, 24(10), 562-569. [doi]  [abs]
  15. Kollins, SH; Braeckman, R; Guenther, S; Barrett, AC; Mickle, TC; Oh, C; Marraffino, A; Cutler, AJ; Brams, MN (2021). A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder.. J Child Adolesc Psychopharmacol, 31(9), 597-609. [doi]  [abs]
  16. Perochon, S; Di Martino, M; Aiello, R; Baker, J; Carpenter, K; Chang, Z; Compton, S; Davis, N; Eichner, B; Espinosa, S; Flowers, J; Franz, L; Gagliano, M; Harris, A; Howard, J; Kollins, SH; Perrin, EM; Raj, P; Spanos, M; Walter, B; Sapiro, G; Dawson, G (2021). A scalable computational approach to assessing response to name in toddlers with autism.. The Journal of Child Psychology and Psychiatry and Allied Disciplines, 62(9), 1120-1131. [doi]  [abs]
  17. Kollins, SH (2007). Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD).. American Journal on Addictions, 16 Suppl 1, 35-42. [17453605], [doi]  [abs]
  18. Carpenter, KLH; Davis, NO; Spanos, M; Sabatos-DeVito, M; Aiello, R; Baranek, GT; Compton, SN; Egger, HL; Franz, L; Kim, S-J; King, BH; Kolevzon, A; McDougle, CJ; Sanders, K; Veenstra-VanderWeele, J; Sikich, L; Kollins, SH; Dawson, G (2022). Adaptive Behavior in Young Autistic Children: Associations with Irritability and ADHD Symptoms.. J Autism Dev Disord. [doi]  [abs]
  19. McClernon, FJ; Kollins, SH (2008). ADHD and smoking: from genes to brain to behavior.. Ann N Y Acad Sci, 1141, 131-147. [18991955], [doi]  [abs]
  20. Levin, FR (2007). ADHD and Sustance Abuse Update. American Journal on Addictions, 16(s1), 1-4. [Gateway.cgi], [doi]
  21. Kollins, SH; Adcock, RA (2014). ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence.. Prog Neuropsychopharmacol Biol Psychiatry, 52, 70-78. [doi]  [abs]
  22. Dew, RE; Kollins, SH; Koenig, HG (2022). ADHD, Religiosity, and Psychiatric Comorbidity in Adolescence and Adulthood.. J Atten Disord, 26(2), 307-318. [doi]  [abs]
  23. Sweitzer, MM; Kollins, SH; Kozink, RV; Hallyburton, M; English, J; Addicott, MA; Oliver, JA; McClernon, FJ (2018). ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge.. Neuropsychopharmacology, 43(4), 851-858. [doi]  [abs]
  24. Kollins, SH (2008). ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.. Journal of Attention Disorders, 12(2), 115-125. [18192623], [doi]  [abs]
  25. Kollins, SH; March, JS (2007). Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder.. Biological Psychiatry, 62(9), 951-953. [17950067], [doi]
  26. Cinnamon Bidwell, L; Dew, RE; Kollins, SH (2010). Alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder.. Current Psychiatry Reports, 12(5), 366-373. [20652773], [doi]  [abs]
  27. Barry, CM; Sabhlok, A; Saba, VC; Majors, AD; Schechter, JC; Levine, EL; Streicher, M; Bennett, GG; Kollins, SH; Fuemmeler, BF (2018). An Automated Text-Messaging Platform for Enhanced Retention and Data Collection in a Longitudinal Birth Cohort: Cohort Management Platform Analysis (Preprint). [doi]  [abs]
  28. Barry, CM; Sabhlok, A; Saba, VC; Majors, AD; Schechter, JC; Levine, EL; Streicher, M; Bennett, GG; Kollins, SH; Fuemmeler, BF (2019). An Automated Text-Messaging Platform for Enhanced Retention and Data Collection in a Longitudinal Birth Cohort: Cohort Management Platform Analysis.. Jmir Public Health and Surveillance, 5(2), e11666. [doi]  [abs]
  29. Van Voorhees, E; McClernon, FJ; Fuemmeler, B; English, J; Holdaway, A; Hallyburton, M; Dew, R; Kollins, S (2012). An examination of differences in variables maintaining smoking behavior in adult smokers with and without attention-deficit/hyperactivity disorder. Addiction Research & Theory, 20(1), 72-81. [doi]  [abs]
  30. Kollins, SH; Schoenfelder, EN; English, JS; Holdaway, A; Van Voorhees, E; O'Brien, BR; Dew, R; Chrisman, AK (2015). An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults.. J Subst Abuse Treat, 48(1), 96-103. [doi]  [abs]
  31. Weisler, RH; Adler, LA; Kollins, SH; Goodman, DW; Hamdani, M; Dirks, B; Childress, AC (2014). Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate.. Neuropsychiatric Disease and Treatment, 10, 1-12. [24363557], [doi]  [abs]
  32. Smith, TF; Anastopoulos, AD; Garrett, ME; Arias-Vasquez, A; Franke, B; Oades, RD; Sonuga-Barke, E; Asherson, P; Gill, M; Buitelaar, JK; Sergeant, JA; Kollins, SH; Faraone, SV; Ashley-Koch, A; IMAGE Consortium, (2014). Angiogenic, neurotrophic, and inflammatory system SNPs moderate the association between birth weight and ADHD symptom severity.. Am J Med Genet B Neuropsychiatr Genet, 165B(8), 691-704. [doi]  [abs]
  33. Fredericks, EM; Kollins, SH (2004). Assessing methylphenidate preference in ADHD patients using a choice procedure.. Psychopharmacology, 175(4), 391-398. [15258716], [doi]  [abs]
  34. Kollins, SH; MacDonald, EK; Rush, CR (2001). Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review.. Pharmacology, Biochemistry, and Behavior, 68(3), 611-627. [11325419], [doi]  [abs]
  35. Mitchell, JT; Van Voorhees, EE; Dennis, MF; McClernon, FJ; Calhoun, PS; Kollins, SH; Beckham, JC (2012). Assessing the role of attention-deficit/hyperactivity disorder symptoms in smokers with and without posttraumatic stress disorder.. Nicotine Tob Res, 14(8), 986-992. [22180583], [doi]  [abs]
  36. Fuemmeler, B; Lee, C-T; Kollins, S; McClernon, JF; Bazemore, S (2014). ASSOCIATION BETWEEN ATTENTION DEFICIT HYPERACTIVITY DISORDER SYMPTOMS AND ILLICIT DRUG USE IN ADD HEALTH SAMPLE. Annals of Behavioral Medicine, 47, S46-S46.
  37. Fuemmeler, BF; Østbye, T; Yang, C; McClernon, FJ; Kollins, SH (2011). Association between attention-deficit/hyperactivity disorder symptoms and obesity and hypertension in early adulthood: a population-based study.. Int J Obes (Lond), 35(6), 852-862. [20975727], [doi]  [abs]
  38. Kollins, SH; McClernon, FJ; Fuemmeler, BF (2005). Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults.. Archives of General Psychiatry, 62(10), 1142-1147. [16203959], [doi]  [abs]
  39. Willoughby, MT; Kollins, SH; McClernon, FJ; Family Life Investigative Group, (2009). Association between smoking and retrospectively reported attention-deficit/hyperactivity disorder symptoms in a large sample of new mothers.. Nicotine Tob Res, 11(3), 313-322. [19307443], [doi]  [abs]
  40. Fuemmeler, BF; Sheng, Y; Schechter, JC; Do, E; Zucker, N; Majors, A; Maguire, R; Murphy, SK; Hoyo, C; Kollins, SH (2020). Associations between attention deficit hyperactivity disorder symptoms and eating behaviors in early childhood.. Pediatr Obes, 15(7), e12631. [doi]  [abs]
  41. Do, EK; Zucker, NL; Huang, ZY; Schechter, JC; Kollins, SH; Maguire, RL; Murphy, SK; Hoyo, C; Fuemmeler, BF (2019). Associations between imprinted gene differentially methylated regions, appetitive traits and body mass index in children.. Pediatr Obes, 14(2), e12454. [doi]  [abs]
  42. Dozmorov, MG; Bilbo, SD; Kollins, SH; Zucker, N; Do, EK; Schechter, JC; Zhang, JJ; Murphy, SK; Hoyo, C; Fuemmeler, BF (2018). Associations between maternal cytokine levels during gestation and measures of child cognitive abilities and executive functioning.. Brain Behav Immun, 70, 390-397. [doi]  [abs]
  43. Maguire, RL; House, JS; Lloyd, DT; Skinner, HG; Allen, TK; Raffi, AM; Skaar, DA; Park, SS; McCullough, LE; Kollins, SH; Bilbo, SD; Collier, DN; Murphy, SK; Fuemmeler, BF; Gowdy, KM; Hoyo, C (2021). Associations between maternal obesity, gestational cytokine levels and child obesity in the NEST cohort.. Pediatr Obes, 16(7), e12763. [doi]  [abs]
  44. Lee, C-T; Clark, TT; Kollins, SH; McClernon, FJ; Fuemmeler, BF (2015). Attention Deficit Hyperactivity Disorder symptoms and smoking trajectories: race and gender differences.. Drug Alcohol Depend, 148, 180-187. [doi]  [abs]
  45. Fuemmeler, BF; Kollins, SH; McClernon, FJ (2007). Attention deficit hyperactivity disorder symptoms predict nicotine dependence and progression to regular smoking from adolescence to young adulthood.. Journal of Pediatric Psychology, 32(10), 1203-1213. [17602186], [doi]  [abs]
  46. Addicott, MA; Pearson, JM; Schechter, JC; Sapyta, JJ; Weiss, MD; Kollins, SH (2021). Attention-deficit/hyperactivity disorder and the explore/exploit trade-off.. Neuropsychopharmacology, 46(3), 614-621. [doi]  [abs]
  47. Lunsford-Avery, JR; Engelhard, MM; Navar, AM; Kollins, SH (2021). Author Correction: Validation of the Sleep Regularity Index in Older Adults and Associations with Cardiometabolic Risk.. Scientific Reports, 11(1), 24398. [doi]
  48. Lunsford-Avery, JR; Engelhard, MM; Navar, AM; Kollins, SH (2020). Author Correction: Validation of the Sleep Regularity Index in Older Adults and Associations with Cardiometabolic Risk.. Scientific Reports, 10(1), 2993. [doi]  [abs]
  49. Phillips, EL; Kollins, S; Edgerly, D (1999). Behavioural assessment of children and adolescents.. The Indian Journal of Pediatrics, 66(3), 389-399. [doi]  [abs]
  50. Murphy, SK; Itchon-Ramos, N; Visco, Z; Huang, Z; Grenier, C; Schrott, R; Acharya, K; Boudreau, M-H; Price, TM; Raburn, DJ; Corcoran, DL; Lucas, JE; Mitchell, JT; McClernon, FJ; Cauley, M; Hall, BJ; Levin, ED; Kollins, SH (2018). Cannabinoid exposure and altered DNA methylation in rat and human sperm.. Epigenetics : Official Journal of the Dna Methylation Society, 13(12), 1208-1221. [doi]  [abs]
  51. Schrott, R; Acharya, K; Itchon-Ramos, N; Hawkey, AB; Pippen, E; Mitchell, JT; Kollins, SH; Levin, ED; Murphy, SK (2020). Cannabis use is associated with potentially heritable widespread changes in autism candidate gene DLGAP2 DNA methylation in sperm.. Epigenetics : Official Journal of the Dna Methylation Society, 15(1-2), 161-173. [doi]  [abs]
  52. Lee, C-T; McClernon, FJ; Kollins, SH; Fuemmeler, BF (2018). Childhood ADHD Symptoms and Future Illicit Drug Use: The Role of Adolescent Cigarette Use.. Journal of Pediatric Psychology, 43(2), 162-171. [doi]  [abs]
  53. Lee, C-T; McClernon, FJ; Kollins, SH; Prybol, K; Fuemmeler, BF (2013). Childhood economic strains in predicting substance use in emerging adulthood: mediation effects of youth self-control and parenting practices.. Journal of Pediatric Psychology, 38(10), 1130-1143. [23899658], [doi]  [abs]
  54. Mitchell, JT; Howard, AL; Belendiuk, KA; Kennedy, TM; Stehli, A; Swanson, JM; Hechtman, L; Arnold, LE; Hoza, B; Vitiello, B; Lu, B; Kollins, SH; Molina, BSG (2019). Cigarette Smoking Progression Among Young Adults Diagnosed With ADHD in Childhood: A 16-year Longitudinal Study of Children With and Without ADHD.. Nicotine Tob Res, 21(5), 638-647. [doi]  [abs]
  55. Posner, K; Melvin, GA; Murray, DW; Gugga, SS; Fisher, P; Skrobala, A; Cunningham, C; Vitiello, B; Abikoff, HB; Ghuman, JK; Kollins, S; Wigal, SB; Wigal, T; McCracken, JT; McGough, JJ; Kastelic, E; Boorady, R; Davies, M; Chuang, SZ; Swanson, JM; Riddle, MA; Greenhill, LL (2007). Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).. Journal of Child and Adolescent Psychopharmacology, 17(5), 547-562. [doi]  [abs]
  56. Kollins, SH; Jain, R; Brams, M; Segal, S; Findling, RL; Wigal, SB; Khayrallah, M (2011). Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD.. Pediatrics, 127(6), e1406-e1413. [21555501], [doi]  [abs]
  57. Jain, R; Segal, S; Kollins, SH; Khayrallah, M (2011). Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder.. J Am Acad Child Adolesc Psychiatry, 50(2), 171-179. [21241954], [doi]  [abs]
  58. Bidwell, LC; McClernon, FJ; Kollins, SH (2011). Cognitive enhancers for the treatment of ADHD.. Pharmacol Biochem Behav, 99(2), 262-274. [21596055], [doi]  [abs]
  59. Mitchell, JT; Schick, RS; Hallyburton, M; Dennis, MF; Kollins, SH; Beckham, JC; McClernon, FJ (2014). Combined ecological momentary assessment and global positioning system tracking to assess smoking behavior: a proof of concept study.. J Dual Diagn, 10(1), 19-29. [doi]  [abs]
  60. Preston, RJ; Kollins, SH; Swanson, JM; Greenhill, LL; Wigal, T; Elliott, GR; Vitiello, B (2005). Comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al.. Cancer Letters, 230(2), 292-294. [16019134], [doi]
  61. Fuemmeler, B; Lee, C-T; Ranby, KW; Stroo, M; Yang, C; Clark, K; Boynton, MH; Clark, T; McClernon, J; Kollins, S (2012). COMMUNITY AND INDIVIDUAL LEVEL SOCIAL CORRELATES OF SMOKING TRAJECTORIES FROM ADOLESCENCE TO ADULTHOOD. Annals of Behavioral Medicine, 43, S210-S210.
  62. Ghuman, JK; Riddle, MA; Vitiello, B; Greenhill, LL; Chuang, SZ; Wigal, SB; Kollins, SH; Abikoff, HB; McCracken, JT; Kastelic, E; Scharko, AM; McGough, JJ; Murray, DW; Evans, L; Swanson, JM; Wigal, T; Posner, K; Cunningham, C; Davies, M; Skrobala, AM (2007). Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).. Journal of Child and Adolescent Psychopharmacology, 17(5), 563-580. [17979578], [doi]  [abs]
  63. Kollins, SH (2003). Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.. The Journal of Clinical Psychiatry, 64 Suppl 11, 14-18. [14529325]  [abs]
  64. Kollins, SH; Rush, CR; Pazzaglia, PJ; Ali, JA (1998). Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate.. Experimental and Clinical Psychopharmacology, 6(4), 367-374. [9861551], [doi]  [abs]
  65. Chang, Z; Di Martino, JM; Aiello, R; Baker, J; Carpenter, K; Compton, S; Davis, N; Eichner, B; Espinosa, S; Flowers, J; Franz, L; Harris, A; Howard, J; Perochon, S; Perrin, EM; Krishnappa Babu, PR; Spanos, M; Sullivan, C; Walter, BK; Kollins, SH; Dawson, G; Sapiro, G (2021). Computational Methods to Measure Patterns of Gaze in Toddlers With Autism Spectrum Disorder.. Jama Pediatr, 175(8), 827-836. [doi]  [abs]
  66. Weissler, EH; Naumann, T; Andersson, T; Ranganath, R; Elemento, O; Luo, Y; Freitag, DF; Benoit, J; Hughes, MC; Khan, F; Slater, P; Shameer, K; Roe, M; Hutchison, E; Kollins, SH; Broedl, U; Meng, Z; Wong, JL; Curtis, L; Huang, E; Ghassemi, M (2021). Correction to: The role of machine learning in clinical research: transforming the future of evidence generation.. Trials, 22(1), 593. [doi]
  67. Jain, R; Segal, S; Kollins, SH; Khayrallah, M (2011). Corrigendum. Journal of the American Academy of Child and Adolescent Psychiatry, 50(3), 313-313. [Gateway.cgi], [doi]
  68. (2019). Corrigendum: Cigarette Smoking Progression Among Young Adults Diagnosed With ADHD in Childhood: A 16-year Longitudinal Study of Children With and Without ADHD.. Nicotine Tob Res, 21(10), 1449. [doi]
  69. Koblan, KS; Hopkins, SC; Sarma, K; Jin, F; Goldman, R; Kollins, SH; Loebel, A (2015). Dasotraline for the treatment of attention-deficit/hyperactivity disorder: A randomized, double-blind, placebo-controlled, proof-of-concept trial in adults. Neuropsychopharmacology, 40(12), 2745-2752. [doi]  [abs]
  70. Koblan, KS; Hopkins, SC; Sarma, K; Jin, F; Goldman, R; Kollins, SH; Loebel, A (2015). Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults.. Neuropsychopharmacology, 40(12), 2745-2752. [doi]  [abs]
  71. Kollins, SH (2003). Delay discounting is associated with substance use in college students.. Addictive Behaviors, 28(6), 1167-1173. [12834659], [doi]  [abs]
  72. Kollins, SH; Shapiro, SK; Newland, MC; Abramowitz, A (1998). Discriminative and participant-rated effects of methylphenidate in children diagnosed with attention deficit hyperactivity disorder (ADHD).. Experimental and Clinical Psychopharmacology, 6(4), 375-389. [9861552], [doi]  [abs]
  73. Rush, CR; Kollins, SH; Pazzaglia, PJ (1998). Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.. Experimental and Clinical Psychopharmacology, 6(1), 32-44. [9526144], [doi]  [abs]
  74. Fuemmeler, BF; Dozmorov, MG; Do, EK; Zhang, JJ; Grenier, C; Huang, Z; Maguire, RL; Kollins, SH; Hoyo, C; Murphy, SK (2021). DNA Methylation in Babies Born to Nonsmoking Mothers Exposed to Secondhand Smoke during Pregnancy: An Epigenome-Wide Association Study.. Environ Health Perspect, 129(5), 57010. [doi]  [abs]
  75. Faraone, SV; Spencer, TJ; Kollins, SH; Glatt, SJ; Goodman, D (2012). Dose response effects of lisdexamfetamine dimesylate treatment in adults with ADHD: an exploratory study.. J Atten Disord, 16(2), 118-127. [21527575], [doi]  [abs]
  76. Adler, LA; Goodman, DW; Kollins, SH; Weisler, RH; Krishnan, S; Zhang, Y; Biederman, J; 303 Study Group, (2008). Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.. The Journal of Clinical Psychiatry, 69(9), 1364-1373. [19012818], [doi]  [abs]
  77. Raman, S; Engelhard, M; Kollins, SH (2019). Driving the Point Home: Novel Approaches to Mitigate Crash Risk for Patients With ADHD.. Pediatrics. [doi]
  78. Taquet, M; Griffiths, K; Palmer, EOC; Ker, S; Liman, C; Wee, SN; Kollins, SH; Patel, R (2023). Early trajectory of clinical global impression as a transdiagnostic predictor of psychiatric hospitalisation: a retrospective cohort study.. Lancet Psychiatry, 10(5), 334-341. [doi]  [abs]
  79. Mitchell, JT; Dennis, MF; English, JS; Dennis, PA; Brightwood, A; Beckham, JC; Kollins, SH (2014). Ecological momentary assessment of antecedents and consequences of smoking in adults with attention-deficit/hyperactivity disorder.. Subst Use Misuse, 49(11), 1446-1456. [doi]  [abs]
  80. Lunsford-Avery, JR; Kollins, SH (2018). Editorial Perspective: Delayed circadian rhythm phase: a cause of late-onset attention-deficit/hyperactivity disorder among adolescents?. The Journal of Child Psychology and Psychiatry and Allied Disciplines, 59(12), 1248-1251. [doi]  [abs]
  81. Kollins, SH (2020). Editorial: From risk prediction to action: leveraging electronic health records to improve pediatric population mental health.. The Journal of Child Psychology and Psychiatry and Allied Disciplines, 61(2), 113-115. [doi]  [abs]
  82. Kollins, SH (2021). Editorial: Is child mental health research structurally racist?. The Journal of Child Psychology and Psychiatry and Allied Disciplines, 62(2), 111-113. [doi]  [abs]
  83. Kollins, SH (2022). Editorial: The gathering storm: a US perspective on the scientific response to the COVID-19 child and adolescent mental health crisis.. The Journal of Child Psychology and Psychiatry and Allied Disciplines, 63(2), 129-131. [doi]
  84. Schechter, J; Do, EK; Zhang, JJ; Hoyo, C; Murphy, SK; Kollins, SH; Fuemmeler, B (2020). Effect of Prenatal Smoke Exposure on Birth Weight: The Moderating Role of Maternal Depressive Symptoms.. Nicotine Tob Res, 22(1), 40-47. [doi]  [abs]
  85. Kollins, SH; Childress, A; Heusser, AC; Lutz, J (2021). Effectiveness of a digital therapeutic as adjunct to treatment with medication in pediatric ADHD.. Npj Digital Medicine, 4(1), 58. [doi]  [abs]
  86. Vitiello, B; Abikoff, HB; Chuang, SZ; Kollins, SH; McCracken, JT; Riddle, MA; Swanson, JM; Wigal, T; McGough, JJ; Ghuman, JK; Wigal, SB; Skrobala, AM; Davies, M; Posner, K; Cunningham, C; Greenhill, LL (2007). Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).. Journal of Child and Adolescent Psychopharmacology, 17(5), 593-604. [17979580], [doi]  [abs]
  87. Connor, DF; Findling, RL; Kollins, SH; Sallee, F; López, FA; Lyne, A; Tremblay, G (2010). Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial.. Cns Drugs, 24(9), 755-768. [20806988], [doi]  [abs]
  88. Faraone, SV; Spencer, TJ; Kollins, SH; Glatt, SJ (2010). Effects of lisdexamfetamine dimesylate treatment for ADHD on growth.. J Am Acad Child Adolesc Psychiatry, 49(1), 24-32. [20215923], [doi]  [abs]
  89. Murray, LK; Kollins, SH (2000). Effects of methylphenidate on sensitivity to reinforcement in children diagnosed with attention deficit hyperactivity disorder: an application of the matching law.. Journal of Applied Behavior Analysis, 33(4), 573-591. [11214032], [doi]  [abs]
  90. Kollins, SH; Garrett, ME; McClernon, FJ; Lachiewicz, AM; Morrissey-Kane, E; FitzGerald, D; Collins, AL; Anastopoulos, AD; Ashley-Koch, AE (2009). Effects of postnatal parental smoking on parent and teacher ratings of ADHD and oppositional symptoms.. J Nerv Ment Dis, 197(6), 442-449. [19525745], [doi]  [abs]
  91. McClernon, FJ; Kollins, SH; Lutz, AM; Fitzgerald, DP; Murray, DW; Redman, C; Rose, JE (2008). Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study.. Psychopharmacology, 197(1), 95-105. [18038223], [doi]  [abs]
  92. Kollins, SH; McClernon, FJ; Epstein, JN (2009). Effects of smoking abstinence on reaction time variability in smokers with and without ADHD: an ex-Gaussian analysis.. Drug Alcohol Depend, 100(1-2), 169-172. [19041198], [doi]  [abs]
  93. Kollins, SH; English, JS; Roley, ME; O'Brien, B; Blair, J; Lane, SD; McClernon, FJ (2013). Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder.. Psychopharmacology (Berl), 227(1), 19-30. [23247366], [doi]  [abs]
  94. Swanson, JM; Moyzis, RK; McGough, JJ; McCracken, JT; Riddle, MA; Kollins, SH; Greenhill, LL; Abikoff, HB; Wigal, T; Wigal, SB; Posner, K; Skrobala, AM; Davies, M; Ghuman, JK; Cunningham, C; Vitiello, B; Stehli, A; Smalley, SL; Grady, D (2007). Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).. Journal of Child and Adolescent Psychopharmacology, 17(5), 635-646. [17979583], [doi]  [abs]
  95. Kollins, SH; Rush, CR (1999). Effects of training dose on the relationship between discriminative-stimulus and self-reported drug effects of d-amphetamine in humans.. Pharmacology, Biochemistry, and Behavior, 64(2), 319-326. [10515308], [doi]  [abs]
  96. Weiss, MD; Cutler, AJ; Kollins, SH; Donnelly, GAE (2021). Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension.. J Child Adolesc Psychopharmacol, 31(9), 610-622. [doi]  [abs]
  97. Greenhill, L; Kollins, S; Abikoff, H; McCracken, J; Riddle, M; Swanson, J; McGough, J; Wigal, S; Wigal, T; Vitiello, B; Skrobala, A; Posner, K; Ghuman, J; Cunningham, C; Davies, M; Chuang, S; Cooper, T (2006). Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD.. Journal of the American Academy of Child and Adolescent Psychiatry, 45(11), 1284-1293. [doi]  [abs]
  98. Wigal, SB; Kollins, SH; Childress, AC; Adeyi, B (2010). Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day.. Child and Adolescent Psychiatry and Mental Health, 4, 32. [21156071], [doi]  [abs]
  99. Sallee, FR; Kollins, SH; Wigal, TL (2012). Efficacy of guanfacine extended release in the treatment of combined and inattentive only subtypes of attention-deficit/hyperactivity disorder.. J Child Adolesc Psychopharmacol, 22(3), 206-214. [22612526], [doi]  [abs]
  100. Childress, AC; Kollins, SH; Cutler, AJ; Marraffino, A; Sikes, CR (2017). Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting.. J Child Adolesc Psychopharmacol, 27(1), 66-74. [doi]  [abs]
  101. Mitchell, JT; Robertson, CD; Anastopolous, AD; Nelson-Gray, RO; Kollins, SH (2012). Emotion dysregulation and emotional impulsivity among adults with attention-deficit/hyperactivity disorder: Results of a preliminary study. Journal of Psychopathology and Behavioral Assessment, 34(4), 510-519. [doi]  [abs]
  102. Kollins, SH; Newland, MC; Critchfield, TS (1997). Erratum to: Human sensitivity to reinforcement in operant choice: How much do consequences matter?. Psychonomic Bulletin & Review, 4(3), 431-431. [Gateway.cgi], [doi]
  103. Bidwell, LC; Dew, RE; Kollins, SH (2011). Erratum: alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder.. Current Psychiatry Reports, 13(1), 76. [21136308], [doi]
  104. Volkow, ND; Wang, G-J; Kollins, SH; Wigal, TL; Newcorn, JH; Telang, F; Fowler, JS; Zhu, W; Logan, J; Ma, Y; Pradhan, K; Wong, C; Swanson, JM (2009). Evaluating dopamine reward pathway in ADHD: clinical implications.. Jama, 302(10), 1084-1091. [19738093], [doi]  [abs]
  105. Lunsford-Avery, JR; Kollins, SH; Mittal, VA (2019). Eveningness diurnal preference associated with poorer socioemotional cognition and social functioning among healthy adolescents and young adults.. Chronobiol Int, 36(3), 439-444. [doi]  [abs]
  106. Lunsford-Avery, JR; Sweitzer, MM; Kollins, SH; Mitchell, JT (2021). Eveningness Diurnal Preference: Putting the "Sluggish" in Sluggish Cognitive Tempo.. J Atten Disord, 25(14), 2060-2067. [doi]  [abs]
  107. Kollins, SH; Greenhill, L (2006). Evidence base for the use of stimulant medication in preschool children with ADHD. Infants & Young Children, 19(2), 132-141. [doi]  [abs]
  108. Kollins, SH; Lane, SD; Shapiro, SK (1997). Experimental analysis of childhood psychopathology: A laboratory matching analysis of the behavior of children diagnosed with Attention-Deficit Hyperactivity Disorder (ADHD). The Psychological Record, 47(1), 25-44. [doi]  [abs]
  109. Hardy, KK; Kollins, SH; Murray, DW; Riddle, MA; Greenhill, L; Cunningham, C; Abikoff, HB; McCracken, JT; Vitiello, B; Davies, M; McGough, JJ; Posner, K; Skrobala, AM; Swanson, JM; Wigal, T; Wigal, SB; Ghuman, JK; Chuang, SZ (2007). Factor structure of parent- and teacher-rated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).. Journal of Child and Adolescent Psychopharmacology, 17(5), 621-634. [17979582], [doi]  [abs]
  110. Daleiden, EL; Chorpita, BF; Kollins, SH; Drabman, RS (1999). Factors affecting the reliability of clinical judgments about the function of children's school-refusal behavior.. Journal of Clinical Child Psychology, 28(3), 396-406. [10446689], [doi]  [abs]
  111. Lunsford-Avery, JR; Keller, C; Kollins, SH; Krystal, AD; Jackson, L; Engelhard, MM (2020). Feasibility and Acceptability of Wearable Sleep Electroencephalogram Device Use in Adolescents: Observational Study (Preprint). [doi]  [abs]
  112. Lunsford-Avery, JR; Keller, C; Kollins, SH; Krystal, AD; Jackson, L; Engelhard, MM (2020). Feasibility and Acceptability of Wearable Sleep Electroencephalogram Device Use in Adolescents: Observational Study.. Jmir Mhealth and Uhealth, 8(10), e20590. [doi]  [abs]
  113. Fuemmeler, BF; Agurs-Collins, TD; McClernon, FJ; Kollins, SH; Kail, ME; Bergen, AW; Ashley-Koch, AE (2008). Genes implicated in serotonergic and dopaminergic functioning predict BMI categories.. Obesity (Silver Spring, Md.), 16(2), 348-355. [18239643], [doi]  [abs]
  114. Markunas, CA; Quinn, KS; Collins, AL; Garrett, ME; Lachiewicz, AM; Sommer, JL; Morrissey-Kane, E; Kollins, SH; Anastopoulos, AD; Ashley-Koch, AE (2010). Genetic variants in SLC9A9 are associated with measures of attention-deficit/hyperactivity disorder symptoms in families.. Psychiatr Genet, 20(2), 73-81. [20032819], [doi]  [abs]
  115. Forsyth, JP; Kollins, S; Palav, A; Duff, K; Maher, S (1999). Has behavior therapy drifted from its experimental roots? A survey of publication trends in mainstream behavioral journals.. Journal of Behavior Therapy and Experimental Psychiatry, 30(3), 205-220. [doi]  [abs]
  116. Engelhard, MM; Berchuck, SI; Garg, J; Henao, R; Olson, A; Rusincovitch, S; Dawson, G; Kollins, SH (2020). Health system utilization before age 1 among children later diagnosed with autism or ADHD.. Scientific Reports, 10(1), 17677. [doi]  [abs]
  117. Mitchell, JT; Weisner, TS; Jensen, PS; Murray, DW; Molina, BSG; Arnold, LE; Hechtman, L; Swanson, JM; Hinshaw, SP; Victor, EC; Kollins, SH; Wells, KC; Belendiuk, KA; Blonde, A; Nguyen, C; Ambriz, L; Nguyen, JL (2018). How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning.. J Atten Disord, 22(9_suppl), 49S-60S. [doi]  [abs]
  118. Kollins, SH; Newland, MC; Critchfield, TS (1997). Human sensitivity to reinforcement in operant choice: How much do consequences matter?. Psychonomic Bulletin & Review, 4(2), 208-220. [21331827], [doi]  [abs]
  119. Ksinan, AJ; Sheng, Y; Do, EK; Schechter, JC; Zhang, JJ; Maguire, RL; Hoyo, C; Murphy, SK; Kollins, SH; Rubin, B; Fuemmeler, BF (2021). Identifying the Best Questions for Rapid Screening of Secondhand Smoke Exposure Among Children.. Nicotine Tob Res, 23(7), 1217-1223. [doi]  [abs]
  120. Lunsford-Avery, JR; Kollins, SH; Kansagra, S; Wang, KW; Engelhard, MM (2022). Impact of daily caffeine intake and timing on electroencephalogram-measured sleep in adolescents.. J Clin Sleep Med, 18(3), 877-884. [doi]  [abs]
  121. Schechter, JC; Fuemmeler, BF; Hoyo, C; Murphy, SK; Zhang, JJ; Kollins, SH (2018). Impact of Smoking Ban on Passive Smoke Exposure in Pregnant Non-Smokers in the Southeastern United States.. International Journal of Environmental Research and Public Health, 15(1). [doi]  [abs]
  122. Polanczyk, G; Caspi, A; Houts, R; Kollins, SH; Rohde, LA; Moffitt, TE (2010). Implications of Extending the ADHD Age-of-Onset Criterion to Age 12. Journal of the American Academy of Child and Adolescent Psychiatry, 49(3), 210-216. [doi]
  123. Polanczyk, G; Caspi, A; Houts, R; Kollins, SH; Rohde, LA; Moffitt, TE (2010). Implications of extending the ADHD age-of-onset criterion to age 12: results from a prospectively studied birth cohort.. J Am Acad Child Adolesc Psychiatry, 49(3), 210-216. [20410710], [doi]  [abs]
  124. Kollins, SH; Sweitzer, MM; McClernon, FJ; Perkins, KA (2020). Increased subjective and reinforcing effects of initial nicotine exposure in young adults with attention deficit hyperactivity disorder (ADHD) compared to matched peers: results from an experimental model of first-time tobacco use.. Neuropsychopharmacology, 45(5), 851-856. [doi]  [abs]
  125. Pettiford, J; Kozink, RV; Lutz, AM; Kollins, SH; Rose, JE; McClernon, FJ (2007). Increases in impulsivity following smoking abstinence are related to baseline nicotine intake and boredom susceptibility.. Addictive Behaviors, 32(10), 2351-2357. [17399907], [doi]  [abs]
  126. Fuemmeler, B; Lee, C-T; Ranby, KW; Clark, T; McClernon, FJ; Yang, C; Kollins, SH (2013). Individual- and community-level correlates of cigarette-smoking trajectories from age 13 to 32 in a U.S. population-based sample.. Drug Alcohol Depend, 132(1-2), 301-308. [23499056], [doi]  [abs]
  127. Fuemmeler, BF; Agurs-Collins, T; McClernon, FJ; Kollins, SH; Garrett, ME; Ashley-Koch, AE (2009). Interactions between genotype and depressive symptoms on obesity.. Behav Genet, 39(3), 296-305. [19337825], [doi]  [abs]
  128. McClernon, FJ; Fuemmeler, BF; Kollins, SH; Kail, ME; Ashley-Koch, AE (2008). Interactions between genotype and retrospective ADHD symptoms predict lifetime smoking risk in a sample of young adults.. Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco, 10(1), 117-127. [18188752], [doi]  [abs]
  129. Vosburg, SK; Faraone, SV; Riley, E; Whitaker, T; Kardish, J; Baker, D; Kollins, SH; Rush, CR (2023). Intranasal Use of Prescription Stimulants Among Adults Aged 18 to 30: Results From A Crowdsourcing Platform.. J Atten Disord, 27(1), 14-25. [doi]  [abs]
  130. Friis-Healy, EA; Nagy, GA; Kollins, SH (2020). It Is Time to REACT: Opportunities for Digital Mental Health Apps to Reduce Mental Health Disparities in Racially and Ethnically Minoritized Groups (Preprint). [doi]  [abs]
  131. Friis-Healy, EA; Nagy, GA; Kollins, SH (2021). It Is Time to REACT: Opportunities for Digital Mental Health Apps to Reduce Mental Health Disparities in Racially and Ethnically Minoritized Groups.. Jmir Mental Health, 8(1), e25456. [doi]  [abs]
  132. García-Marín, LM; Campos, AI; Cuéllar-Partida, G; Medland, SE; Kollins, SH; Rentería, ME (2021). Large-scale genetic investigation reveals genetic liability to multiple complex traits influencing a higher risk of ADHD.. Scientific Reports, 11(1), 22628. [doi]  [abs]
  133. Childress, AC; Findling, RL; Wu, J; Kollins, SH; Wang, Y; Martin, P; Robertson, B (2020). Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder.. J Child Adolesc Psychopharmacol, 30(3), 128-136. [doi]  [abs]
  134. Kollins, SH; Youcha, S; Lasser, R; Thase, ME (2011). Lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder in adults with a history of depression or history of substance use disorder.. Innov Clin Neurosci, 8(2), 28-32. [21468295]  [abs]
  135. Dew, RE; Kollins, SH (2010). Lisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD.. Expert Opin Pharmacother, 11(17), 2907-2913. [20979573], [doi]  [abs]
  136. Wang, G-J; Volkow, ND; Wigal, T; Kollins, SH; Newcorn, JH; Telang, F; Logan, J; Jayne, M; Wong, CT; Han, H; Fowler, JS; Zhu, W; Swanson, JM (2013). Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder.. Plos One, 8(5), e63023. [23696790], [doi]  [abs]
  137. McCullough, LE; Miller, EE; Calderwood, LE; Shivappa, N; Steck, SE; Forman, MR; A Mendez, M; Maguire, R; Fuemmeler, BF; Kollins, SH; D Bilbo, S; Huang, Z; Murtha, AP; Murphy, SK; Hébert, JR; Hoyo, C (2017). Maternal inflammatory diet and adverse pregnancy outcomes: Circulating cytokines and genomic imprinting as potential regulators?. Epigenetics : Official Journal of the Dna Methylation Society, 12(8), 688-697. [doi]  [abs]
  138. Sanchez, CE; Barry, C; Sabhlok, A; Russell, K; Majors, A; Kollins, SH; Fuemmeler, BF (2018). Maternal pre-pregnancy obesity and child neurodevelopmental outcomes: a meta-analysis.. Obes Rev, 19(4), 464-484. [doi]  [abs]
  139. Witt, KL; Shelby, MD; Itchon-Ramos, N; Faircloth, M; Kissling, GE; Chrisman, AK; Ravi, H; Murli, H; Mattison, DR; Kollins, SH (2008). Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD.. J Am Acad Child Adolesc Psychiatry, 47(12), 1375-1383. [18978633], [doi]  [abs]
  140. Kollins, SH; Schoenfelder, E; English, JS; McClernon, FJ; Dew, RE; Lane, SD (2013). Methylphenidate does not influence smoking-reinforced responding or attentional performance in adult smokers with and without attention deficit hyperactivity disorder (ADHD).. Exp Clin Psychopharmacol, 21(5), 375-384. [24099358], [doi]  [abs]
  141. Abikoff, HB; Vitiello, B; Riddle, MA; Cunningham, C; Greenhill, LL; Swanson, JM; Chuang, SZ; Davies, M; Kastelic, E; Wigal, SB; Evans, L; Ghuman, JK; Kollins, SH; McCracken, JT; McGough, JJ; Murray, DW; Posner, K; Skrobala, AM; Wigal, T (2007). Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).. Journal of Child and Adolescent Psychopharmacology, 17(5), 581-592. [17979579], [doi]  [abs]
  142. Addicott, MA; Schechter, JC; Sapyta, JJ; Selig, JP; Kollins, SH; Weiss, MD (2019). Methylphenidate increases willingness to perform effort in adults with ADHD.. Pharmacol Biochem Behav, 183, 14-21. [doi]  [abs]
  143. Volkow, ND; Wang, G-J; Tomasi, D; Kollins, SH; Wigal, TL; Newcorn, JH; Telang, FW; Fowler, JS; Logan, J; Wong, CT; Swanson, JM (2012). Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.. Journal of Neuroscience, 32(3), 841-849. [22262882], [doi]  [abs]
  144. Mitchell, JT; Zylowska, L; Kollins, SH (2015). Mindfulness Meditation Training for Attention-Deficit/Hyperactivity Disorder in Adulthood: Current Empirical Support, Treatment Overview, and Future Directions.. Cognitive and Behavioral Practice, 22(2), 172-191. [doi]  [abs]
  145. Kollins, SH; McClernon, FJ; Van Voorhees, EE (2010). Monetary incentives promote smoking abstinence in adults with attention deficit hyperactivity disorder (ADHD).. Exp Clin Psychopharmacol, 18(3), 221-228. [20545386], [doi]  [abs]
  146. Volkow, ND; Wang, G-J; Newcorn, JH; Kollins, SH; Wigal, TL; Telang, F; Fowler, JS; Goldstein, RZ; Klein, N; Logan, J; Wong, C; Swanson, JM (2011). Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway.. Mol Psychiatry, 16(11), 1147-1154. [20856250], [doi]  [abs]
  147. Kollins, SH (2018). Moving Beyond Symptom Remission to Optimize Long-term Treatment of Attention-Deficit/Hyperactivity Disorder.. Jama Pediatr, 172(10), 901-902. [doi]
  148. Patel, R; Wee, SN; Ramaswamy, R; Thadani, S; Tandi, J; Garg, R; Calvanese, N; Valko, M; Rush, AJ; Rentería, ME; Sarkar, J; Kollins, SH (2022). NeuroBlu, an electronic health record (EHR) trusted research environment (TRE) to support mental healthcare analytics with real-world data.. Bmj Open, 12(4), e057227. [doi]  [abs]
  149. Lee, C-T; Fuemmeler, BF; McClernon, FJ; Ashley-Koch, A; Kollins, SH (2013). Nicotinic receptor gene variants interact with attention deficient hyperactive disorder symptoms to predict smoking trajectories from early adolescence to adulthood.. Addict Behav, 38(11), 2683-2689. [23899432], [doi]  [abs]
  150. Childress, AC; Kollins, SH; Cutler, AJ; Marraffino, A; Sikes, CR (2021). Open-Label Dose Optimization of Methylphenidate Extended-Release Orally Disintegrating Tablet in a Laboratory Classroom Study of Children with Attention-Deficit/Hyperactivity Disorder.. J Child Adolesc Psychopharmacol, 31(5), 342-349. [doi]  [abs]
  151. Murray, DW; Kollins, SH; Hardy, KK; Abikoff, HB; Swanson, JM; Cunningham, C; Vitiello, B; Riddle, MA; Davies, M; Greenhill, LL; McCracken, JT; McGough, JJ; Posner, K; Skrobala, AM; Wigal, T; Wigal, SB; Ghuman, JK; Chuang, SZ (2007). Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).. Journal of Child and Adolescent Psychopharmacology, 17(5), 605-620. [17979581], [doi]  [abs]
  152. White, MJ; Schechter, JC; Neely, B; Reyes, C; Maguire, RL; Perrin, EM; Ksinan, AJ; Kollins, SH; Fuemmeler, BF (2022). Parenting Stress, Child Weight-Related Behaviors, and Child Weight Status.. Child Obes, 18(3), 150-159. [doi]  [abs]
  153. Engelhard, M; Berchuck, S; Garg, J; Rusincovitch, S; Dawson, G; Kollins, S (2021). Patterns of Health Services Use Before Age 1 in Children Later Diagnosed With ADHD.. J Atten Disord, 25(12), 1639. [doi]  [abs]
  154. McGOUGH, J; McCRACKEN, J; Swanson, J; Riddle, M; Kollins, S; Greenhill, L; Abikoff, H; Davies, M; Chuang, S; Wigal, T; Wigal, S; Posner, K; Skrobala, A; Kastelic, E; Ghuman, J; Cunningham, C; Shigawa, S; Moyzis, R; Vitiello, B (2006). Pharmacogenetics of methylphenidate response in preschoolers with ADHD.. Journal of the American Academy of Child and Adolescent Psychiatry, 45(11), 1314-1322. [doi]  [abs]
  155. Young, JR; Yanagihara, A; Dew, R; Kollins, SH (2021). Pharmacotherapy for Preschool Children with Attention Deficit Hyperactivity Disorder (ADHD): Current Status and Future Directions.. Cns Drugs, 35(4), 403-424. [doi]  [abs]
  156. Vitiello, B; Lazzaretto, D; Yershova, K; Abikoff, H; Paykina, N; McCracken, JT; McGough, JJ; Kollins, SH; Greenhill, LL; Wigal, S; Wigal, T; Riddle, MA (2015). Pharmacotherapy of the Preschool ADHD Treatment Study (PATS) Children Growing Up.. J Am Acad Child Adolesc Psychiatry, 54(7), 550-556. [doi]  [abs]
  157. Franz, L; Howard, J; Viljoen, M; Sikich, L; Chandrasekhar, T; Kollins, SH; Lee, L; Ndlovu, M; Sabatos-DeVito, M; Seris, N; Shabalala, N; Spanos, M; de Vries, PJ; Dawson, G (2022). Pragmatic adaptations of telehealth-delivered caregiver coaching for children with autism in the context of COVID-19: Perspectives from the United States and South Africa.. Autism, 26(1), 270-275. [doi]  [abs]
  158. Fuemmeler, BF; Hoyo, C; Murphy, S; Vidal, AC; Kollins, SH (2015). PRE-PREGNANCY OBESITY AND OFFSPRING NEUROBEHAVIORAL DEVELOPMENT. Annals of Behavioral Medicine, 49, S252-S252. [Gateway.cgi]
  159. Fuemmeler, BF; Zucker, N; Sheng, Y; Sanchez, CE; Maguire, R; Murphy, SK; Kollins, SH; Hoyo, C (2019). Pre-Pregnancy Weight and Symptoms of Attention Deficit Hyperactivity Disorder and Executive Functioning Behaviors in Preschool Children.. International Journal of Environmental Research and Public Health, 16(4). [doi]  [abs]
  160. Fuemmeler, BF; Glasgow, TE; Schechter, JC; Maguire, R; Sheng, Y; Bidopia, T; Barsell, DJ; Ksinan, A; Zhang, J; Lin, Y; Hoyo, C; Murphy, S; Qin, J; Wang, X; Kollins, S (2023). Prenatal and Childhood Smoke Exposure Associations with Cognition, Language, and Attention-Deficit/Hyperactivity Disorder.. J Pediatr, 256, 77-84.e1. [doi]  [abs]
  161. Schechter, JC; Kollins, SH (2017). Prenatal Smoke Exposure and ADHD: Advancing the Field.. Pediatrics, 139(2), e20163481. [doi]
  162. Davis, NO; Bower, J; Kollins, SH (2018). Proof-of-concept study of an at-home, engaging, digital intervention for pediatric ADHD.. Plos One, 13(1), e0189749. [doi]  [abs]
  163. Epstein, JN; Kollins, SH (2006). Psychometric properties of an adult ADHD diagnostic interview.. Journal of Attention Disorders, 9(3), 504-514. [16481667], [doi]  [abs]
  164. Kollins, SH; López, FA; Vince, BD; Turnbow, JM; Farrand, K; Lyne, A; Wigal, SB; Roth, T (2011). Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorder.. J Child Adolesc Psychopharmacol, 21(2), 111-120. [21476931], [doi]  [abs]
  165. Laforett, DR; Murray, DW; Kollins, SH (2008). Psychosocial treatments for preschool-aged children with Attention-Deficit Hyperactivity Disorder.. Dev Disabil Res Rev, 14(4), 300-310. [19072758], [doi]  [abs]
  166. Kollins, SH; Newland, MC; Critchfield, TS (1999). Quantitative integration of single-subject studies: Methods and misinterpretations.. The Behavior Analyst, 22(2), 149-157. [22478332], [doi]  [abs]
  167. Childress, AC; Kollins, SH; Foehl, HC; Newcorn, JH; Mattingly, G; Kupper, RJ; Adjei, AL (2020). Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR) in Preschool Children with Attention-Deficit/Hyperactivity Disorder.. J Child Adolesc Psychopharmacol, 30(2), 58-68. [doi]  [abs]
  168. Kollins, S; Greenhill, L; Swanson, J; Wigal, S; Abikoff, H; McCRACKEN, J; Riddle, M; McGOUGH, J; Vitiello, B; Wigal, T; Skrobala, A; Posner, K; Ghuman, J; Davies, M; Cunningham, C; Bauzo, A (2006). Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS).. Journal of the American Academy of Child and Adolescent Psychiatry, 45(11), 1275-1283. [doi]  [abs]
  169. Sweitzer, MM; Pacek, LR; Kozink, RV; Locey, E; Kollins, SH; Donny, EC; McClernon, FJ (2021). Reactions to reduced nicotine content cigarettes in a sample of young adult, low-frequency smokers.. Psychopharmacology (Berl), 238(9), 2429-2438. [doi]  [abs]
  170. Schrott, R; Murphy, SK; Modliszewski, JL; King, DE; Hill, B; Itchon-Ramos, N; Raburn, D; Price, T; Levin, ED; Vandrey, R; Corcoran, DL; Kollins, SH; Mitchell, JT (2021). Refraining from use diminishes cannabis-associated epigenetic changes in human sperm.. Environmental Epigenetics, 7(1), dvab009. [doi]  [abs]
  171. Lunsford-Avery, JR; Wang, KW; Kollins, SH; Chung, RJ; Keller, C; Engelhard, MM (2022). Regularity and Timing of Sleep Patterns and Behavioral Health Among Adolescents.. J Dev Behav Pediatr, 43(4), 188-196. [doi]  [abs]
  172. Kollins, SH; English, J; Robinson, R; Hallyburton, M; Chrisman, AK (2009). Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD).. Psychopharmacology (Berl), 204(1), 73-83. [19104775], [doi]  [abs]
  173. Van Voorhees, EE; Hardy, KK; Kollins, SH (2011). Reliability and validity of self- and other-ratings of symptoms of ADHD in adults.. J Atten Disord, 15(3), 224-234. [20424007], [doi]  [abs]
  174. Faraone, SV; Childress, A; Wigal, SB; Kollins, SH; McDonnell, MA; DeSousa, NJ; Sallee, FR (2018). Reliability and Validity of the Daily Parent Rating of Evening and Morning Behavior Scale, Revised.. J Atten Disord, 22(11), 1066-1073. [doi]  [abs]
  175. Wigal, T; Greenhill, L; Chuang, S; McGOUGH, J; Vitiello, B; Skrobala, A; Swanson, J; Wigal, S; Abikoff, H; Kollins, S; McCRACKEN, J; Riddle, M; Posner, K; Ghuman, J; Davies, M; Thorp, B; Stehli, A (2006). Safety and tolerability of methylphenidate in preschool children with ADHD.. Journal of the American Academy of Child and Adolescent Psychiatry, 45(11), 1294-1303. [doi]  [abs]
  176. AD Anastopoulos, TF Smith, ME Garrett, E Morrissey-Kane, NK Schatz, JL Sommer, SH Kollins, A Ashley-Koch (2010). Self-Regulation of Emotion, Functional Impairment, and Comorbidity Among Children With ADHD.. Journal of attention disorders. [doi]  [abs]
  177. Anastopoulos, AD; Smith, TF; Garrett, ME; Morrissey-Kane, E; Schatz, NK; Sommer, JL; Kollins, SH; Ashley-Koch, A (2011). Self-Regulation of Emotion, Functional Impairment, and Comorbidity Among ChildrenWith AD/HD.. J Atten Disord, 15(7), 583-592. [20686097], [doi]  [abs]
  178. Gao, L; Liu, X; Millstein, J; Siegmund, KD; Dubeau, L; Maguire, RL; Jim Zhang, J; Fuemmeler, BF; Kollins, SH; Hoyo, C; Murphy, SK; Breton, CV (2018). Self-reported prenatal tobacco smoke exposure, AXL gene-body methylation, and childhood asthma phenotypes.. Clin Epigenetics, 10(1), 98. [doi]  [abs]
  179. Kollins, SH; Rush, CR (2002). Sensitization to the cardiovascular but not subject-rated effects of oral cocaine in humans.. Biological Psychiatry, 51(2), 143-150. [11822993], [doi]  [abs]
  180. Van Voorhees, EE; Mitchell, JT; McClernon, FJ; Beckham, JC; Kollins, SH (2012). Sex, ADHD symptoms, and smoking outcomes: an integrative model.. Med Hypotheses, 78(5), 585-593. [22341778], [doi]  [abs]
  181. Breslav, ADS; Zucker, NL; Schechter, JC; Majors, A; Bidopia, T; Fuemmeler, BF; Kollins, SH; Huettel, SA (2022). Shuffle the Decks: Children Are Sensitive to Incidental Nonrandom Structure in a Sequential-Choice Task.. Psychol Sci, 33(4), 550-562. [doi]  [abs]
  182. Lunsford-Avery, JR; Krystal, AD; Kollins, SH (2016). Sleep disturbances in adolescents with ADHD: A systematic review and framework for future research.. Clin Psychol Rev, 50, 159-174. [doi]  [abs]
  183. Lunsford-Avery, JR; Damme, KSF; Engelhard, MM; Kollins, SH; Mittal, VA (2020). Sleep/Wake Regularity Associated with Default Mode Network Structure among Healthy Adolescents and Young Adults.. Scientific Reports, 10(1), 509. [doi]  [abs]
  184. Mitchell, JT; Davis, NO; Kollins, SH; Lunsford-Avery, JR (2020). Sluggish cognitive tempo (SCT) in an adult outpatient sample seeking an attention-deficit/hyperactivity disorder assessment: Age of onset and assessment method impact on SCT rates.. J Psychiatr Res, 131, 203-208. [doi]  [abs]
  185. Lunsford-Avery, JR; Kollins, SH; Mitchell, JT (2021). Sluggish Cognitive Tempo in Adults Referred for an ADHD Evaluation: A Psychometric Analysis of Self- and Collateral Report.. J Atten Disord, 25(3), 322-331. [doi]  [abs]
  186. Fallavollita, WL; Do, EK; Schechter, JC; Kollins, SH; Zheng, JJ; Qin, J; Maguire, RL; Hoyo, C; Murphy, SK; Fuemmeler, BF (2021). Smoke-Free Home Rules and Association with Child Secondhand Smoke Exposure among Mother-Child Dyad Relationships.. International Journal of Environmental Research and Public Health, 18(10), 5256. [doi]  [abs]
  187. Mitchell, JT; McClernon, FJ; Beckham, JC; Brown, RA; Lejuez, CW; Kollins, SH (2019). Smoking abstinence effects on emotion dysregulation in adult cigarette smokers with and without attention-deficit/hyperactivity disorder.. Drug Alcohol Depend, 205, 107594. [doi]  [abs]
  188. Mitchell, JT; McIntyre, EM; McClernon, FJ; Kollins, SH (2014). Smoking motivation in adults with attention-deficit/hyperactivity disorder using the Wisconsin inventory of smoking dependence motives.. Nicotine Tob Res, 16(1), 120-125. [24078759], [doi]  [abs]
  189. Kozink, RV; Kollins, SH; McClernon, FJ (2010). Smoking withdrawal modulates right inferior frontal cortex but not presupplementary motor area activation during inhibitory control.. Neuropsychopharmacology, 35(13), 2600-2606. [20861830], [doi]  [abs]
  190. McClernon, FJ; Van Voorhees, EE; English, J; Hallyburton, M; Holdaway, A; Kollins, SH (2011). Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change: results from a 12-day contingency-managed abstinence trial.. Nicotine Tob Res, 13(9), 784-792. [21571687], [doi]  [abs]
  191. Xue, H; Maguire, RL; Liu, J; Kollins, SH; Murphy, SK; Hoyo, C; Fuemmeler, BF (2019). Snacking frequency and dietary intake in toddlers and preschool children.. Appetite, 142, 104369. [doi]  [abs]
  192. Kollins, SH; Anastopoulos, AD; Lachiewicz, AM; FitzGerald, D; Morrissey-Kane, E; Garrett, ME; Keatts, SL; Ashley-Koch, AE (2008). SNPs in dopamine D2 receptor gene (DRD2) and norepinephrine transporter gene (NET) are associated with continuous performance task (CPT) phenotypes in ADHD children and their families.. Am J Med Genet B Neuropsychiatr Genet, 147B(8), 1580-1588. [18821566], [doi]  [abs]
  193. Adjei, A; Kupper, RJ; Teuscher, NS; Wigal, S; Sallee, F; Childress, A; Kollins, SH; Greenhill, L (2014). Steady-state bioavailability of extended-release methylphenidate (MPH-MLR) capsule vs. immediate-release methylphenidate tablets in healthy adult volunteers.. Clin Drug Investig, 34(11), 795-805. [doi]  [abs]
  194. Schoenfelder, EN; Faraone, SV; Kollins, SH (2014). Stimulant treatment of ADHD and cigarette smoking: a meta-analysis.. Pediatrics, 133(6), 1070-1080. [doi]  [abs]
  195. Swanson, J; Greenhill, L; Wigal, T; Kollins, S; Stehli, A; Davies, M; Chuang, S; Vitiello, B; Skrobala, A; Posner, K; Abikoff, H; Oatis, M; McCRACKEN, J; McGOUGH, J; Riddle, M; Ghuman, J; Cunningham, C; Wigal, S (2006). Stimulant-related reductions of growth rates in the PATS.. Journal of the American Academy of Child and Adolescent Psychiatry, 45(11), 1304-1313. [doi]  [abs]
  196. Kollins, S (2010). Subjective Effects of Methylphenidate, 275-304. [doi]  [abs]
  197. Critchfield, TS; Kollins, SH (2001). Temporal discounting: basic research and the analysis of socially important behavior.. Journal of Applied Behavior Analysis, 34(1), 101-122. [11317983], [doi]  [abs]
  198. Rizzi, TS; Arias-Vasquez, A; Rommelse, N; Kuntsi, J; Anney, R; Asherson, P; Buitelaar, J; Banaschewski, T; Ebstein, R; Ruano, D; Van der Sluis, S; Markunas, CA; Garrett, ME; Ashley-Koch, AE; Kollins, SH; Anastopoulos, AD; Hansell, NK; Wright, MJ; Montgomery, GW; Martin, NG; Harris, SE; Davies, G; Tenesa, A; Porteous, DJ; Starr, JM; Deary, IJ; St Pourcain, B; Davey Smith, G; Timpson, NJ; Evans, DM; Gill, M; Miranda, A; Mulas, F; Oades, RD; Roeyers, H; Rothenberger, A; Sergeant, J; Sonuga-Barke, E; Steinhausen, HC; Taylor, E; Faraone, SV; Franke, B; Posthuma, D (2011). The ATXN1 and TRIM31 genes are related to intelligence in an ADHD background: evidence from a large collaborative study totaling 4,963 subjects.. Am J Med Genet B Neuropsychiatr Genet, 156(2), 145-157. [21302343], [doi]  [abs]
  199. TS Rizzi, A Arias-Vasquez, N Rommelse, J Kuntsi, R Anney, P Asherson, J Buitelaar, T Banaschewski, R Ebstein, D Ruano, S Van der Sluis, CA Markunas, ME Garrett, AE Ashley-Koch, SH Kollins, AD Anastopoulos, NK Hansell, MJ Wright, GW Montgomery, NG Martin, SE Harris, G Davies, A Tenesa, DJ Porteous, JM Starr, IJ Deary, B St Pourcain, GD Smith, NJ Timpson, DM Evans, M Gill, A Miranda, F Mulas, RD Oades, H Roeyers, A Rothenberger, J Sergeant, E Sonuga-Barke, HC Steinhausen, E Taylor, SV Faraone, B Franke, D Posthuma (2010). The ATXN1 and TRIM31 Genes Are Related to Intelligence in an ADHD Background: Evidence From a Large Collaborative Study Totaling 4,963 Subjects.. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. [doi]  [abs]
  200. Childress, AC; Brams, M; Cutler, AJ; Kollins, SH; Northcutt, J; Padilla, A; Turnbow, JM (2015). The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study.. J Child Adolesc Psychopharmacol, 25(5), 402-414. [doi]  [abs]
  201. Critchfield, TS; Newland, MC; Kollins, SH (2000). The good, the bad, and the aggregate.. The Behavior Analyst, 23(1), 107-115. [22478342], [doi]  [abs]
  202. Engelhard, MM; Kollins, SH (2019). The Many Channels of Screen Media Technology in ADHD: a Paradigm for Quantifying Distinct Risks and Potential Benefits.. Current Psychiatry Reports, 21(9), 90. [doi]  [abs]
  203. Riddle, MA; Yershova, K; Lazzaretto, D; Paykina, N; Yenokyan, G; Greenhill, L; Abikoff, H; Vitiello, B; Wigal, T; McCracken, JT; Kollins, SH; Murray, DW; Wigal, S; Kastelic, E; McGough, JJ; dosReis, S; Bauzó-Rosario, A; Stehli, A; Posner, K (2013). The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up.. J Am Acad Child Adolesc Psychiatry, 52(3), 264-278.e2. [23452683], [doi]  [abs]
  204. Weissler, EH; Naumann, T; Andersson, T; Ranganath, R; Elemento, O; Luo, Y; Freitag, DF; Benoit, J; Hughes, MC; Khan, F; Slater, P; Shameer, K; Roe, M; Hutchison, E; Kollins, SH; Broedl, U; Meng, Z; Wong, JL; Curtis, L; Huang, E; Ghassemi, M (2021). The role of machine learning in clinical research: transforming the future of evidence generation.. Trials, 22(1), 537. [doi]  [abs]
  205. Faraone, SV; Banaschewski, T; Coghill, D; Zheng, Y; Biederman, J; Bellgrove, MA; Newcorn, JH; Gignac, M; Al Saud, NM; Manor, I; Rohde, LA; Yang, L; Cortese, S; Almagor, D; Stein, MA; Albatti, TH; Aljoudi, HF; Alqahtani, MMJ; Asherson, P; Atwoli, L; Bölte, S; Buitelaar, JK; Crunelle, CL; Daley, D; Dalsgaard, S; Döpfner, M; Espinet, S; Fitzgerald, M; Franke, B; Gerlach, M; Haavik, J; Hartman, CA; Hartung, CM; Hinshaw, SP; Hoekstra, PJ; Hollis, C; Kollins, SH; Sandra Kooij, JJ; Kuntsi, J; Larsson, H; Li, T; Liu, J; Merzon, E; Mattingly, G; Mattos, P; McCarthy, S; Mikami, AY; Molina, BSG; Nigg, JT; Purper-Ouakil, D; Omigbodun, OO; Polanczyk, GV; Pollak, Y; Poulton, AS; Rajkumar, RP; Reding, A; Reif, A; Rubia, K; Rucklidge, J; Romanos, M; Ramos-Quiroga, JA; Schellekens, A; Scheres, A; Schoeman, R; Schweitzer, JB; Shah, H; Solanto, MV; Sonuga-Barke, E; Soutullo, C; Steinhausen, H-C; Swanson, JM; Thapar, A; Tripp, G; van de Glind, G; van den Brink, W; Van der Oord, S; Venter, A; Vitiello, B; Walitza, S; Wang, Y (2021). The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder.. Neurosci Biobehav Rev, 128, 789-818. [doi]  [abs]
  206. Schoenfelder, EN; Kollins, SH (2016). Topical Review: ADHD and Health-Risk Behaviors: Toward Prevention and Health Promotion.. Journal of Pediatric Psychology, 41(7), 735-740. [doi]  [abs]
  207. Davis, NO; Kollins, SH (2012). Treatment for co-occurring attention deficit/hyperactivity disorder and autism spectrum disorder.. Neurotherapeutics, 9(3), 518-530. [22678458], [doi]  [abs]
  208. Ranby, KW; Boynton, MH; Kollins, SH; McClernon, FJ; Yang, C; Fuemmeler, BF (2012). Understanding the phenotypic structure of adult retrospective ADHD symptoms during childhood in the United States.. J Clin Child Adolesc Psychol, 41(3), 261-274. [22394329], [doi]  [abs]
  209. Kollins, SH; Barkley, RA; DuPaul, GJ (2001). Use and management of medications for children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Focus on Exceptional Children, 33(5), X-24. [doi]
  210. Kollins, SH; Barkley, RA; DuPaul, GJ (2001). Use and management of medications for children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Focus on Exceptional Children, 33(5), X-24.
  211. Kollins, SH; Barkley, RA; DuPaul, GJ (2001). Use and management of medications for children diagnosed with attention deficit hyperactivity disorder (ADHD). Focus on Exceptional Children, 33(5), 1-+.
  212. Lunsford-Avery, JR; Engelhard, MM; Navar, AM; Kollins, SH (2018). Validation of the Sleep Regularity Index in Older Adults and Associations with Cardiometabolic Risk.. Scientific Reports, 8(1), 14158. [doi]  [abs]

Chapters in Books

  1. Lunsford-Avery, JR; Kollins, SH; Krystal, AD "0762 Sleeping at Home: Feasibility and Tolerability of Ambulatory Polysomnography for Use with Adolescents with Attention-Deficit/Hyperactivity Disorder."  Oxford University Press (OUP), April, 2018: A283-A284. [doi]
  2. Childress, AC; Kollins, SH; Wu, J; Robertson, B "2.22 Lisdexamfetamine Dimesylate for Preschool Children With ADHD."  Elsevier BV, October, 2018: S165-S166. [doi]
  3. Kollins, SH; Bower, J; Findling, RL; Keefe, R; Epstein, J; Cutler, AJ; White, R; Aberle, L; DeLoss, D; Faraone, SV "2.40 A Multicenter, Randomized, Active-Control Registration Trial of Software Treatment for Actively Reducing Severity of ADHD (Stars-Adhd) to Assess the Efficacy and Safety of a Novel, Home-Based, Digital Treatment for Pediatric ADHD."  Elsevier BV, October, 2018: S172-S172. [doi]
  4. Mitchell, JT; Howard, AL; Swanson, JM; Kennedy, TM; Stehli, A; Belendiuk, KA; Kollins, SH; Molina, BSG "21.2 Substance Use Among Children With and Without Attention-Deficit/Hyperactivity Disorder Followed Prospectively Into Early Adulthood in the MTA."  Elsevier BV, October, 2017: S334-S335. [doi]
  5. Kollins, SH "37.4 COMPUTER-BASED AND PARENT-REPORTED ASSESSMENT OF EXECUTIVE FUNCTIONING: METHOD VARIANCE AND IMPLICATIONS FOR INTERPRETING FINDINGS FROM ADHD EFFICACY TRIALS."  Elsevier BV, October, 2019: S356-S356. [doi]
  6. Childress, AC; Kollins, SH; Adjei, AL; Haddock, P; Foehl, HC; Mattingly, G; Newcorn, JH "4.15 The Efficacy and Safety of Methylphenidate Hydrochloride (HCL) Extended-Release in Preschool Aged Children With ADHD."  Elsevier BV, October, 2018: S209-S209. [doi]
  7. Ann Catherine Childress, ; Kollins, SH; Cutler, AJ; Marraffino, A; Sikes, C "5.10 EFFICACY AND SAFETY OF AN EXTENDED-RELEASE, ORALLY DISINTEGRATING METHYLPHENIDATE TABLET IN CHILDREN 6-12 YEARS OF AGE BASED ON ADHD RATING SCALE-IV SCORE AT BASELINE."  Elsevier BV, October, 2020: S152-S152. [doi]
  8. Epstein, JN; Lutz, J; DeLoss, D; Kollins, SH "5.13 EXPLORING ENGAGEMENT AS A FACTOR FOR EFFICACY WITH AKL-T01, A HOME-BASED DIGITAL THERAPEUTIC."  Elsevier BV, October, 2020: S153-S153. [doi]
  9. Kollins, SH; Heusser, A; Lutz, J "5.25 STARS-ADJUNCT: A HOME-BASED, DIGITAL TREATMENT FOR PEDIATRIC ADHD AS ADJUNCT TO STIMULANT MEDICATION: INSIGHTS ON REPEAT ADMINISTRATION AND THE STABILITY OF EFFECTS."  Elsevier BV, October, 2020: S157-S157. [doi]
  10. Childress, AC; Lutz, J; Kollins, SH "5.26 STARS-ADJUNCT: AKL-T01, A DIGITAL TREATMENT FOR PEDIATRIC ADHD AS AN ADJUNCT TO STIMULANT MEDICATION: RESPONSE RATES WITH REPEAT ADMINISTRATION."  Elsevier BV, October, 2020: S157-S157. [doi]
  11. Davis, N; Lutz, J; Kollins, SH "5.27 STARS-ADJUNCT: AKL-T01, A HOME-BASED DIGITAL INTERVENTION AS AN ADJUNCT TO STIMULANT MEDICATION FOR PEDIATRIC ADHD: ACADEMIC PERFORMANCE AND RELATION TO OBJECTIVE MEASURES OF ATTENTION."  Elsevier BV, October, 2020: S157-S158. [doi]
  12. Kollins, SH; Cutler, AJ; Khattak, S; Weiss, MD; Donnelly, G; Reiz, JL "6.41 A SIX-MONTH OPEN-LABEL MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF PRC-063 IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER."  Elsevier BV, October, 2016: S217-S217. [doi]
  13. Kollins, SH; Cutler, AJ; Khattak, S; Weiss, MD; Donnelly, G; Reiz, JL "6.42 A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY MEASURING THE EFFICACY AND SAFETY OF A NOVEL, EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE (PRC-063) IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER."  Elsevier BV, October, 2016: S217-S218. [doi]
  14. Chen, S; Perera, R; Engelhard, MM; Lunsford-Avery, JR; Kollins, SH; Fuemmeler, BF "A generic algorithm for sleep-wake cycle detection using unlabeled actigraphy data."  May, 2019 [doi]  [abs]
  15. McDonnell, M; Wigal, S; Childress, A; Kollins, S; DeSousa, N; Komolova, M; Sallee, F "A Treatment Optimization Study of HLD200 in Children with Attention-Deficit/Hyperactivity Disorder."  2016: S391-S391.
  16. Kollins, SH "Abuse potential of stimulant drugs used to treat ADHD." ADHD in Adults: Characterization, Diagnosis, and Treatment. Cambridge University Press, January, 2011: 230-239. [doi]  [abs]
  17. Kollins, SH; McClernon, FJ "ADHD and smoking." Attention-Deficit Hyperactivity Disorder in Adults and Children. Cambridge University Press, January, 2015: 327-342. [doi]  [abs]
  18. Mitchell, JT; Kollins, SH "ADHD in adolescence." Adolescent health psychology. Ed. O'Donohue, W; Benuto, L; Tolle, L SPRINGER, 2013: 423-445.
  19. Sweitzer, M; Kollins, S; Kozink, R; Hallyburton, M; English, J; Addicott, M; Oliver, J; McClernon, F "ADHD, Smoking Withdrawal, and Resting State Functional Connectivity: Results of a fMRI Study With Methylphenidate Challenge."  NATURE PUBLISHING GROUP, December, 2016: S614-S615.
  20. Lusby, CM; Kollins, SH "Attention-deficit/hyperactivity disorder and college students." Principles and Practice of College Health. December, 2020: 77-85. [doi]  [abs]
  21. Mitchell, JT; Kollins, SH "Attention-deficit/hyperactivity disorder in adolescence." Handbook of Adolescent Health Psychology. Springer New York, January, 2013: 423-445. [doi]
  22. Witt, KL; Shelby, MD; Itchon-Ramos, N; Faircloth, M; Kissling, GE; Chrisman, AK; Ravi, H; Murli, H; Mattison, DR; Kollins, SH "Chromosomal aberrations, sister chromatid exchanges, and micronuclei in lymphocytes of pediatric ADHD patients treated with stimulant drugs."  WILEY-BLACKWELL, August, 2008: 528-528. [Gateway.cgi]
  23. Wang, G-J; Volkow, N; Wigal, T; Kollins, S; Newcorn, J; Telang, F; Logan, J; Wong, C; Fowler, JS; Swanson, JM "Chronic treatment with methylphenidate increases dopamine transporter density in patients with attention deficit hyperactive disorder."  2009
  24. Kollins, SH; Wigal, T; Vince, B; Lyne, A; Farrand, K "Cognitive and sedative effects of guanfacine extended release in children and adolescents aged 6 to 17 years with attention-deficit/hyperactivity disorder: Safety and sleep effects."  ELSEVIER SCIENCE INC, April, 2008: 246S-246S. [Gateway.cgi]
  25. McClernon, FJ; Mitchell, JT; Schick, RS; Bayham, RL; Dennis, ME; Kollins, SH; Beckham, JC "COMBINED EMA AND GPS FOR ASSESSING THE SPATIAL DISTRIBUTION OF SMOKING BEHAVIOR: A PROOF OF CONCEPT STUDY."  SPRINGER, March, 2013: S93-S93.
  26. Kollins, SH; Epstein, JN; Keith Conners, C "Corners' rating scales-revised." The Use of Psychological Testing for Treatment Planning and Outcomes Assessment: Volume 2: Instruments for Children and Adolescents. April, 2014: 215-233.
  27. Koblan, K; Hopkins, S; Sarma, K; Jin, F; Goldman, R; Loebel, A; Kollins, S "Dasotraline as a Novel DAT/NET Inhibitor for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-concept Trial in Adults."  NATURE PUBLISHING GROUP, December, 2014: S347-S347.
  28. Kollins, S; Levin, E; Price, T; Murphy, S "Delta-9-Tetrahydrocannabinol Exposure Alters Sperm Methylation Profiles: Concurrent Results From Humans and Rats."  NATURE PUBLISHING GROUP, November, 2017: S642-S643.
  29. Volkow, ND; Wang, G-J; Kollins, S; Wigal, T; Newcorn, J; Telang, F; Fowler, J; Swanson, J "Dopamine's Role in ADHD Symptoms: Beyond an Attention Deficit."  2010: 96S-96S.
  30. Kollins, SH "Duration of Effect of a Novel, Home-Based, Digital Treatment for Pediatric ADHD."  Elsevier BV, October, 2019: S296-S296. [doi]
  31. Connor, D; Kollins, S; Findling, R; Lopez, F; Sallee, F; Lyne, A; Tremblay, G "Effects of Guanfacine Extended Release in Children Aged 6 to 12 Years with Oppositional Symptoms and a Diagnosis of Attention-Deficit/Hyperactivity Disorder."  2010: 217S-217S.
  32. Goodman, D; Adler, L; Kollins, SH; Weisler, R; Krishnan, S; Zhang, Y; Biederman, J "Efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder."  CAMBRIDGE UNIV PRESS, July, 2008: 292-293. [Gateway.cgi]
  33. Murphy, SK; Schrott, R; Visco, Z; Huang, Z; Grenier, C; Mitchell, J; Schechter, J; Lucas, J; Levin, ED; Price, T; Kollins, SH "Environment and Gametic Epigenetic Reprogramming.."  WILEY, September, 2017: S28-S28.
  34. Kollins, S; Epstein, J; Tonev, S; Anastopoulos, A; Lachiewicz, A; Fitzgerald, D; Kane, E; Kail, M; Cuccaro, M; Exelbierd, L; Gilbert, J; Ashley-Koch, A "Genetic associations with reaction time variability in AD/HD."  WILEY-LISS, October, 2006: 771-772.
  35. Bidwell, LC; Garrett, ME; McClernon, FJ; Fuemmeler, BF; Williams, RB; Ashley-Koch, AE; Kollins, SH "Genotype and ADHD symptoms interact to predict adolescents' early smoking experiences in an epidemiological sample."  SPRINGER, November, 2011: 893-893. [Gateway.cgi]
  36. Kollins, S; McClernon, F; English, J; Hood, D; Perkins, K "Initial Response to Intranasal Nicotine Young Adults With and Without Attention Deficit Hyperactivity Disorder."  2016: S452-S453.
  37. Volkow, N; Wang, G-J; Tomasi, D; Kollins, S; Wigal, T; Newcorn, J; Telang, F; Fowler, J; Logan, J; Swanson, J "Methylphenidate induced dopamine increases in striatum and temporal and frontal cortices predicts response to treatment in ADHD."  2011
  38. Turnbow, J; Kollins, S; Lopez, F; Lyne, A; Youcha, S; Rubin, J "Response to Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD)."  2010: 218S-218S.
  39. Bidopia, T; Engelhard, MM; Kollins, SH; Lunsford-Avery, JR "Screen media technology and ADHD in children and adolescents: Potential perils and emerging opportunities." Encyclopedia of Child and Adolescent Health, First Edition. January, 2023: 260-274. [doi]  [abs]
  40. Lunsford-Avery, JR; Krystal, AD; Carskadon, MA; Kollins, SH "SLEEP ASSOCIATED WITH EXECUTIVE FUNCTIONING AMONG ADOLESCENTS ACROSS THE ADHD CONTINUUM."  2020: A373-A373.
  41. Glasgow, TE; Adams, EL; Ksinan, A; Barsell, DJ; Lunsford-Avery, J; Chen, S; Kollins, S; Schechter, JC; Maguire, R; Engelhard, M; Fuemmeler, BF "Sleep onset, duration, or regularity: which matters most for child adiposity outcomes?."  August, 2022: 1502-1509. [doi]  [abs]
  42. Schug, MD; Anastopoulos, A; Kollins, S; Hennis, L; Nelson, S; Mehltretter, L; Gilbert, J; Cuccaro, M; Ashley-Koch, A "The genetics of AD/HD: Subtyping, comorbidity and developmental considerations."  WILEY-LISS, September, 2004: 103-103.
  43. Wang, G-J; Volkow, N; Wigal, T; Kollins, S; Newcorn, J; Telang, F; Logan, J; Wong, C; Fowler, J; Swanson, J "Tolerance to the dopaminergic effects of methylphenidate in adults with ADHD after one-year treatment with methylphenidate."  2010

Duke University * Arts & Sciences * Faculty * Staff * Grad * Postdocs * Reload * Login